Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report

Authors

  • Sunil Kumar Das Department of General Practice and Emergency Medicine, Patan Academy of Health Sciences, Lagankhel, Lalitpur, Nepal https://orcid.org/0000-0002-6568-5149
  • Arun Shahi Department of Oncology, Patan Academy of Health Sciences, Lagankhel, Lalitpur, Nepal
  • Ram Chandra Panthi Department of Internal Medicine, Patan Academy of Health Sciences, Lagankhel, Lalitpur, Nepal

DOI:

https://doi.org/10.31729/jnma.7081

Keywords:

chemotherapy; choriocarcinoma; metastasis; recurrence.

Abstract

Choriocarcinoma is a malignant trophoblastic tumour usually of placental origin. It is characterized by early metastasis to the brain and lungs. With early detection, it has a better prognosis with treatment. We report a case of 18 years female at 26 weeks of gestation in her third pregnancy who had a history of treatment for metastatic gestational trophoblastic neoplasm with chemotherapy and radiotherapy two years back. Therefore, she was managed as a case of recurrent choriocarcinoma with brain metastasis with chemotherapy (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) and was responsive. Her symptoms resolved and β-human chorionic gonadotropin dropped to normal value (<2.39 mIU/ml) which has shown that timely diagnosis and management can be vital for the successful treatment of brain metastasis.

Downloads

Published

2022-05-05

How to Cite

Das, S. K., Shahi, A. ., & Panthi, R. C. . (2022). Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report. Journal of Nepal Medical Association, 60(249), 488–490. https://doi.org/10.31729/jnma.7081

Most read articles by the same author(s)